Avinger, Inc. (AVGR): Price and Financial Metrics

Avinger, Inc. (AVGR): $0.56

0.00 (-0.78%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add AVGR to Watchlist
Sign Up

AVGR Price/Volume Stats

Current price $0.56 52-week high $2.10
Prev. close $0.57 52-week low $0.42
Day low $0.53 Volume 21,400
Day high $0.58 Avg. volume 178,661
50-day MA $0.63 Dividend yield N/A
200-day MA $1.08 Market Cap 6.00M

AVGR Stock Price Chart Interactive Chart >

AVGR Stock Summary

  • AVINGER INC's market capitalization of $6,519,005 is ahead of only 2.51% of US-listed equities.
  • AVINGER INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 2.88% of US listed stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for AVGR comes in at -79.38% -- higher than that of only 7.26% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to AVINGER INC, a group of peers worth examining would be CLRO, UPC, SRTS, NBRV, and HUDI.
  • AVGR's SEC filings can be seen here. And to visit AVINGER INC's official web site, go to www.avinger.com.

AVGR Valuation Summary

  • AVGR's EV/EBIT ratio is -0.7; this is 105.83% lower than that of the median Healthcare stock.
  • Over the past 101 months, AVGR's price/sales ratio has gone down 11.1.

Below are key valuation metrics over time for AVGR.

Stock Date P/S P/B P/E EV/EBIT
AVGR 2023-05-23 0.8 -4.2 -0.3 -0.7
AVGR 2023-05-22 0.8 -4.4 -0.3 -0.7
AVGR 2023-05-19 0.8 -4.3 -0.3 -0.7
AVGR 2023-05-18 0.7 -4.2 -0.3 -0.7
AVGR 2023-05-17 0.7 -4.1 -0.3 -0.7
AVGR 2023-05-16 0.7 -3.8 -0.3 -0.6

AVGR Growth Metrics

    The year over year cash and equivalents growth rate now stands at -34.29%.
  • Its 3 year price growth rate is now at -98.32%.
  • The 3 year cash and equivalents growth rate now stands at 19.75%.
AVGR's revenue has moved down $1,720,000 over the prior 15 months.

The table below shows AVGR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 8.675 -17.574 -27.972
2022-06-30 8.789 -17.7 -28.714
2022-03-31 9.459 -17.075 -26.869
2021-12-31 10.13 -15.697 -21.587
2021-09-30 10.459 -15.33 -21.143
2021-06-30 10.395 -14.984 -20.679

AVGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AVGR has a Quality Grade of D, ranking ahead of 16.95% of graded US stocks.
  • AVGR's asset turnover comes in at 0.276 -- ranking 136th of 186 Medical Equipment stocks.
  • HOLX, ICAD, and BTCY are the stocks whose asset turnover ratios are most correlated with AVGR.

The table below shows AVGR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.276 0.353 -1.054
2021-03-31 0.257 0.332 -1.360
2020-12-31 0.288 0.299 -1.795
2020-09-30 0.306 0.298 -2.297
2020-06-30 0.336 0.303 -2.235
2020-03-31 0.369 0.314 -1.990

AVGR Price Target

For more insight on analysts targets of AVGR, see our AVGR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.50 Average Broker Recommendation 1.5 (Moderate Buy)

Avinger, Inc. (AVGR) Company Bio


Avinger, Inc. designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease in the United States and Europe. The company was founded in 2007 and is based in Redwood City, California.


AVGR Latest News Stream


Event/Time News Detail
Loading, please wait...

AVGR Latest Social Stream


Loading social stream, please wait...

View Full AVGR Social Stream

Latest AVGR News From Around the Web

Below are the latest news stories about AVINGER INC that investors may wish to consider to help them evaluate AVGR as an investment opportunity.

Q1 2023 Avinger Inc Earnings Call

Q1 2023 Avinger Inc Earnings Call

Yahoo | May 11, 2023

Avinger Reports First Quarter 2023 Results

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the first quarter ended March 31, 2023.

Yahoo | May 10, 2023

Avinger to Announce First Quarter 2023 Results on May 10

Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the first quarter 2023 after the close of trading on Wednesday, May 10, 2023.

Yahoo | May 2, 2023

Leading Data on the Treatment of In-Stent Restenosis with Pantheris Presented at Charing Cross International Symposium

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the presentation of clinical data from the INSIGHT study during the Charing Cross (CX) International Symposium in London, England.

Yahoo | April 28, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

The biggest pre-market stock movers are ready to go as we dive into the latest news traders need to know about on Thursday!

William White on InvestorPlace | April 27, 2023

Read More 'AVGR' Stories Here

AVGR Price Returns

1-mo 14.68%
3-mo -47.17%
6-mo -55.56%
1-year N/A
3-year -92.47%
5-year -99.84%
YTD -48.39%
2022 -87.94%
2021 2.25%
2020 -61.39%
2019 -62.00%
2018 -95.83%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!